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Abstract
Background: Intracranial aneurysms (IA) are increasingly recognized as a disease driven by chronic inflammation.
Recent research has identified key mediators and processes underlying IA pathogenesis, but mechanistic
understanding remains incomplete. Lymphocytic infiltrates have been demonstrated in patient IA tissue specimens
and have also been shown to play an important role in abdominal aortic aneurysms (AAA) and related diseases such as
atherosclerosis. However, no study has systematically examined the contribution of lymphocytes in a model of IA.
Methods: Lymphocyte-deficient (Rag1) and wild-type (WT; C57BL/6 strain) mice were subjected to a robust IA
induction protocol. Rates of IA formation and rupture were measured, and cerebral artery tissue was collected
and utilized for histology and gene expression analysis.
Results: At 2 weeks, the Rag1 group had significantly fewer IA formations and ruptures than the WT group.
Histological analysis of unruptured IA tissue showed robust B and T lymphocyte infiltration in the WT group,
while there were no differences in macrophage infiltration, IA diameter, and wall thickness. Significant differences
in interleukin-6 (IL-6), matrix metalloproteinases 2 (MMP2) and 9 (MMP9), and smooth muscle myosin heavy chain
(MHC) were observed between the groups.
Conclusions: Lymphocytes are key contributors to IA pathogenesis and provide a novel target for the prevention of IA
progression and rupture in patients.
Keywords: Leukocyte, Interleukin-6, Inflammation, Cerebral aneurysm, Subarachnoid hemorrhage, Matrix
metalloproteinase 2, Matrix metalloproteinase 9, Myosin heavy chain, Rag1 mice
Background
Intracranial aneurysms (IA) are important cerebrovascu-
lar diseases with a prevalence of 1–5 % [1, 2] although
the incidence increases to 19 % in high-risk populations
[3]. Approximately 6–20 per 100,000 patients per year
will experience a life-threatening subarachnoid
hemorrhage (SAH) as the result of IA rupture [4–8].
Although SAH accounts for only 3–8 % of all strokes
[9], it is a disproportionate contributor to stroke burden.
The prognosis of SAH patients is poor with a fatality
rate of up to 50 % making it a significant contributor to
stroke deaths in a relatively young population with a
mean age of 50 years [10–12]. There is a critical need
for better understanding of IA pathogenesis in order to
provide improved early diagnosis and pharmacological
treatment alternatives to patients who are at high risk
for surgical interventions.
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Ongoing work to elucidate the mechanisms behind IA
pathogenesis promises to provide new targets for the
diagnosis and treatment of this disease. Current under-
standing characterizes IA as a chronic inflammatory dis-
ease. The initiation of pathogenesis likely occurs with
damage to the endothelium of the blood vessels in the
cerebral circulation which recruits an inflammatory re-
sponse that ultimately compromises the integrity of the
vessel wall [13]. Key features of this process include a
loss of the internal elastic lamina, myointimal hyperpla-
sia, and ectopic distribution of vascular smooth muscle
cells (VSMC) [14]. Many of these changes are influenced
by the infiltration of leukocytes into the vessel wall
which can act to degrade the extracellular matrix (ECM)
through the secretion of MMPs and promote VSMC
phenotypic modulation via secretion of cytokines such
as tissue necrosis factor (TNF), interleukin-1 beta, and
interleukin-6 (IL-6) [13]. Activated VSMC undergo de-
differentiation which is characterized by a reduction in
contractile and cytoskeletal gene expression and in-
creased expression of genes involved in the proliferation,
migration, and matrix remodeling [15]. Inflammatory
cell infiltration (macrophages and T lymphocytes and
subsequently B lymphocytes) is followed by tissue fibro-
sis which is present in all ruptured IA [16].
The role of macrophages in IA formation and rup-
ture has been well-characterized [17], yet the presence
of other leukocyte populations has been noted in both
IA and abdominal aortic aneurysms (AAA). A study of
patient AAA tissue showed a reduction of VSMC
markers, macrophage infiltration, and increased CD4+
and CD8+ T lymphocyte populations compared to
healthy aorta. The presence of these inflammatory cells
was also correlated with high levels of DNA fragmen-
tation in VSMC [18]. There is also evidence that lym-
phocytes are localized in IA lesions suggesting that
they may play a role in the inflammatory cascade
underlying the disease. Studies of human tissue
resected during clipping of IAs have shown that both T
and B lymphocytes robustly infiltrate the vessel wall,
preferentially around areas of IA rupture [19, 20]. Add-
itionally, the presence of T lymphocytic infiltrate is as-
sociated with areas of myointimal hyperplasia in
ruptured IA [21]. Although clear relationships have
been demonstrated, it is impossible to determine from
these studies whether lymphocytes exert a causal effect
on the formation or rupture of IA.
Lymphocytes have been shown to have important ef-
fects in aneurysm-related inflammatory diseases such as
atherosclerosis. T lymphocytes promote inflammation in
atherosclerotic plaques via secretion of TNF and inter-
feron gamma (IFNγ) which activates macrophages and B
lymphocytes and increases expression of endothelial ad-
hesion molecules [22–24]. B lymphocytes are involved in
modulating the uptake of oxidized lipids by macro-
phages and can also contribute to endothelial damage
[14]. Atherosclerotic lesions are found in all cerebral an-
eurysms histologically, and progression of atherosclerosis
has correlated positively with aneurysm growth [20].
However, the mechanisms by which lymphocytes may
contribute to cerebral aneurysm pathogenesis remain
undefined.
The aim of the present study was to examine the role
of lymphocytes in IA pathogenesis using a well-
characterized murine model of IA. The experiments
compared IA formation and rupture in mice deficient in
lymphocytes (Rag1 knockouts, which do not produce
mature B or T cells) to wild-type (WT) C57BL/6 mice.
The tissue was collected from the animals for histology
and gene expression analysis in order to examine the




Animal surgery procedures were approved by the Tulane
Institutional Animal Care and Use Committee. Eight-
week-old WT and lymphocyte-deficient mice (Rag1, on
C57BL/6 background) (Jackson Laboratories) were used
to induce IA via a previously described method involving
induced hypertension and stereotactic elastase injection
[25, 26]. In brief, animals underwent a unilateral
nephrectomy followed 1 week later by a single stereotac-
tic injection of 35 mU of elastase (Sigma-Aldrich) into
the cerebrospinal fluid of the basal cistern. A subcutane-
ous pellet of deoxycorticosterone acetate (50 mg, 21-day
release, Innovative Research of America) was also placed
during this second surgery, after which the animals were
given water containing 1.0 % NaCl until the conclusion
of the study. All survival surgeries were performed under
anesthesia using 100 mg/kg ketamine/10 mg/kg xylazine.
Animals were monitored daily for changes in weight
or neurological function and those that lost more than
2.0 g of body mass in a 24-h period or displayed signifi-
cant neurologic impairment were euthanized and
necropsied to confirm the occurrence of SAH. All
remaining mice were euthanized 14 days after elastase
injection. These animals were perfused via intracardiac
injection with phosphate-buffered saline (PBS) followed
by a 2 mg/ml bromophenol blue (Thermo Fisher Scien-
tific) in 4.0 % gelatin (Sigma-Aldrich) solution which
allowed for visualization of the cerebral vessels. Brain
samples were collected, and the cerebral vessels were
carefully evaluated by a blinded observer for the pres-
ence of IA and SAH [25] then digitally imaged and dis-
sected using an Olympus SZX7 stereomicroscope.
Aneurysms were defined as a localized outward bulging
of the vascular wall whose diameter was greater than 1.5
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times the parent artery diameter by two independent ob-
servers blinded to the animal cohort. The number and
location of IA and ruptures were recorded, and the IA
tissue was collected and stored at −80 °C.
Flow cytometry
At the experimental endpoint, the spleen tissue from
each animal was collected and homogenized in order to
quantify the lymphocyte population in the WT group
and confirm the lymphocyte-deficient phenotype of the
Rag1 animals. The number of cells collected from each
spleen was determined using a hemocytometer, after
which cells were stained using fluorescein (FITC)- and
phycoerythrin (PE)-conjugated antibodies to CD2 (T
cells, FITC; BD Biosciences) and CD19 (B cells, PE; BD
Biosciences) and analyzed using a Beckman-Coulter Gal-
lios™ flow cytometer. An absolute number of lympho-
cytes collected from each animal was calculated using
spleen cellularity and proportion of cells expressing
lymphocyte markers.
Histology
The IA tissue was embedded in O.C.T. (Tissue-Tek) and
flash frozen in isopentane (2-methyl butane) pre-chilled to
−176 °C in liquid nitrogen. Eight-micrometer cryosections
were collected using a CM1860 cryostat (Leica Microsys-
tems). For immunofluorescence, slides were post-fixed in
acetone for 10 min at −20 °C then equilibrated to room
temperature. All slides were stained using Tris-buffered
saline/Tween 20 (TBS/T) solutions. Slides were rinsed
with TBS/T, blocked in 5 % serum (species of the second-
ary antibody) for 30 min, stained with an anti-CD68
(1:100; Abcam) antibody, or double labeled with anti-CD3
(SP7, 1:100; Abcam) and anti-CD19 (6D5, 1:100; Abcam)
antibodies for 2 h then rinsed in TBS/T. Alexa Fluor 488
rabbit anti-rat and 594 goat anti-rabbit (both 1:300; Life
Technologies) secondary antibodies were used to label the
tissue for 1 h followed by nuclear labeling with DAPI
(1:300; Life Technologies) for 5 min. ProLong Gold
mounting media (Life Technologies) was used to prevent
photobleaching during imaging. Cryosections were also
stained with a Verhoeff van Gieson (VVG) kit (Poly-
sciences, Inc.) to label connective tissues. Images (×100
and ×200) were collected using an Olympus IX73 inverted
microscope with identical capture settings for each stain.
Histomorphometry was performed on the CD68 and
VVG stains using ImageJ software (National Institutes of
Health). For the CD68 stain, three ×200 images for each
animal were obtained at identical exposure times and
analyzed by calculation of corrected tissue fluorescence
(CTF) [27]. The area of the tissue section was traced
and measured in square micrometers, and the integrated
density, i.e., total fluorescent intensity, was determined
for each traced region. Integrated density for unstained
background was also measured. The CTF was calculated
using the following formula:
CTF ¼ Integrated density
− ðArea of selected tissue
Mean fluorescence of background readingsÞ
For the VVG stain, IA circumference, inner and outer
diameter, and wall thickness were measured in microme-
ters at the widest point for each animal using ×100
images. Averages were determined using three images
per animal per group.
Quantitative real-time RT-PCR
The circle of Willis tissue was collected and stored at
−80 °C in RNAlater solution (Life Technologies).
Samples were pooled for the treatment groups, homoge-
nized using a Scilogex D160, and RNA was extracted
with Trizol reagent (Life Technologies) according to the
manufacturer’s instructions. DNase post-treatment was
performed on the samples using a DNA-free™ kit (Life
Technologies) to remove genomic DNA contamination.
cDNA was prepared with 0.5 μg total RNA per reaction
using a Transcriptor First Strand cDNA kit (Roche Diag-
nostics), and mRNA expression was quantified with
SYBR Green (Roche Diagnostics) on a Light Cycler 96
real-time system (Roche Diagnostics) and normalized to
beta actin gene expression. Fold change is expressed
over WT native tissue. Experiments were performed in
triplicates with n = 3 reactions per group. Primer
sequences are listed in Table 1.
Statistics
Rates of IA formation and rupture in each group were eval-
uated using a Fisher’s exact test while histomorphometry
and RT-PCR data were analyzed with a Student’s t test or
one-way ANOVA with Bonferroni post hoc test using Sig-
maPlot 11.2 software (Systat Software Inc.). All data are
expressed as mean ± SEM, and p ≤ 0.05 is considered statis-
tically significant.
Results
Lymphocyte-deficient animals develop fewer cerebral
aneurysms and have a lower incidence of aneurysm
rupture
Rates of IA formation and rupture were measured over the
course of the experiment, and digital images of each brain
were collected showing outcomes with no IA formation
(Fig. 1a), IA formation (Fig. 1b), and IA rupture with SAH
(Fig. 1c). The mean number of IAs formed per animal was
2.0 ± 0.42 in the WT group (n = 19) and 0.88 ± 0.21 in the
Rag1 group (n = 17, p = 0.036) (Fig. 1d). The mean number
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of ruptures that occurred per animal was 1.16 ± 0.25 in the
WT group (n = 19) and 0.41 ± 0.12 in the Rag1 group
(n = 17, p = 0.026) (Fig. 1e). The rupture rate (percent-
age of animals that formed IAs in each group that suffered
at least one rupture) was 100 % in the WT group (n = 16)
and 63.6 % in the Rag1 group (n = 11, p = 0.031) (Fig. 1f).
Rag1 animals exhibit similar macrophage infiltration but
absent lymphocyte infiltration in cerebral aneurysms
The VVG stain allowed visualization of internal elastic
lamina degeneration, thrombosis, and cellular infiltration
for each group [28] (Fig. 2a, b). Quantification of unrup-
tured IA diameter (Rag1 508.11 ± 92.10 μm, WT 367.14
± 65.36 μm) and IA wall thickness (Rag1 70.60 ±
6.09 μm, WT 54.35 ± 11.08 μm) was not significantly dif-
ferent between the groups (Fig. 2c, d). Macrophage infil-
tration in the IA tissue was confirmed in all animals
with the CD68 stain (Fig. 3a, b). CD68 CTF quantifica-
tion for the WT group (81.21 ± 16.33 AU, n = 5) showed
no significant differences from the Rag1 group (64.85 ±
18.60 AU, n = 6, p = 0.34, Fig. 3c).
The lymphocyte-deficient phenotype of the Rag1 animals
was confirmed by flow cytometry studies of spleen cell sus-
pensions at the conclusion of the experiment. The propor-
tion of spleen cells expressing lymphocyte markers (CD2 or
CD19) was found to be 0.43 in the WT group (n = 9) and
0.043 in the Rag1 group (n = 10, p < 0.0001, data not
shown). The mean number of cells expressing lymphocyte
Table 1 Quantitative real-time RT-PCR primer sequences
Gene Forward Reverse
Beta actin GATCATTGCTCCTCCTGAG ATCGTACTCCTGCTTGCT
Tissue necrosis factor TCGTAGCAAACCACCAAG AGCCTTGTCCCTTGAAGA
Interferon-γ GTATTGCCAAGTTTGAGGTC AATCAGCAGCGACTCCTT
Interleukin-6 ATTCATATCTTCAACCAAGAGG TCCTTAGCCACTCCTTCT
Matrix metalloproteinase 2 GGAGACAAGTTCTGGAGATA GGTTATCAGGGATGGCATT
Matrix metalloproteinase 9 GACATCTTCCAGTACCAAG CCACCTTGTTCACCTCAT
Smooth muscle myosin heavy chain CAGCTTGTCAGGAAGGAATA TGACAGCACCTTCTACCT
Smooth muscle actin CTTTCATTGGGATGGAGTCA GGCTGTGATCTCCTTCTG
Transgelin (SM22) TGTTCCAGACTGTTGACCT AGTTGGCTGTCTGTGAAGT
Fig. 1 Rag1 knockout animals show less IA formation and rupture. Representative images of cerebral arteries at 14 days and quantification of
IA formation and rupture. Scale bars = 2 mm. a No IA formation. b Unruptured IA. c Ruptured IA producing SAH. Rag1 group has significantly
lower total IAs per animal (d) and ruptured IAs per animal (e). f Rag1 group has significantly lower rate of IA rupture. *p≤ 0.05
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markers (lymphocyte proportion multiplied by spleen cellu-
larity) was 18.88 × 106 in the WT group and 0.14 × 106 in
the Rag1 group (Fig. 4a, p = 0.0003).
Robust B and T lymphocyte infiltration was confirmed
in the WT group by immunofluorescent staining with
CD19 and CD3 antibodies in the harvested IA tissue at
2 weeks (Fig. 4b) while no lymphocytes were present in
the Rag1 tissue (Fig. 4c).
Lymphocyte depletion alters vessel wall changes
associated with cerebral aneurysm pathogenesis
Quantitative RT-PCR mRNA expression was normalized
to native uninjured cerebral artery tissue from WT
animals (C57BL/6 native). Expression of VSMC marker
genes smooth muscle alpha actin (SMA) and SM22 were
significantly decreased in both animal groups (SMA fold
change 0.55 ± 0.059 WT versus 0.46 ± 0.033 Rag1, SM22
fold change 0.59 ± 0.043 WT versus 0.62 ± 0.060 Rag1)
compared to native tissue while MHC gene repression
was attenuated in the Rag1 group (fold change 0.51 ±
0.037 versus 0.15 ± 0.015 WT, Fig. 5a).
IA induction increased the expression of matrix re-
modeling genes MMP2 and MMP9 in the WT group
while this increase was significantly diminished in the
Rag1 group (fold change 3.79 ± 0.25 MMP2, 6.82 ± 0.71
MMP9, p < 0.001, versus 2.23 ± 0.34 MMP2, 2.13 ± 0.33
MMP9 in the WT versus Rag1 group, respectively
Fig. 5b).
Fig. 2 VVG stain for elastic fibers and quantification of IA diameter and wall thickness. Elastic fibers and nuclei (black) and collagen (red). a ×100
VVG and b ×200 representative image of Rag1 unruptured IA. Scale bars = 100 and 50 μm. No significant difference between average IA diameter
(c) and wall thickness (d) between Rag1 and WT groups
Fig. 3 Macrophage CD68 immunostaining and quantification. a ×200 images of WT and b Rag1 IA tissue. Scale bars = 50 μm. c No significant
differences in CD68 macrophage fluorescence between WT and Rag1 groups
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IA induction did not alter IFNγ while TNFα was up-
regulated similarly in both groups (fold change 3.53 ±
0.35 and 3.51 ± 0.22, p < 0.001, versus WT native in the
WT experimental and Rag1 experimental groups, re-
spectively, Fig. 5c). IL-6 gene expression was significantly
increased in the Rag1 group (fold change 66.83 ± 12.70,
p < 0.001) compared to the WT experimental group
(11.82 ± 2.61, Fig. 5d).
Discussion
Lymphocytes are a well-defined component of chronic
inflammation in many disease states and have been
Fig. 4 Splenic B and T lymphocyte populations and lymphocyte infiltration in WT IA tissue. a Number of CD19/CD2-positive B and T lymphocytes
2 weeks after IA induction. ×200 images of CD19 (green) and CD3 (red) double immunostaining show B and T lymphocyte infiltration in the WT
(b) and not the Rag1 IA tissue (c). Scale bars = 50 μm
Fig. 5 RT-PCR relative quantification of mRNA expression shows significant differences between the WT and Rag1 experimental groups.
Smooth muscle marker genes (a), matrix metalloproteinases (b), and inflammatory genes (c, d). **p≤ 0.01; ***p≤ 0.001
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implicated as a contributing factor in vascular pathology
such as atherosclerosis and AAA [14, 18, 29]. Although
multiple investigators have reported the presence of
these cells in patient IA tissue specimens, it was not pre-
viously known whether they play a causative role in the
pathogenesis of the disease. This study used a well-
characterized mouse model of IA to examine the effect
of lymphocyte depletion on IA disease progression and
its underlying mechanisms.
The present results provide evidence that lymphocytes
are directly involved in the pathogenesis and rupture of
IA. The Rag1 animals were confirmed to have negligible
numbers of cells expressing lymphocyte markers in the
spleen and in the walls of intracranial vessels, as com-
pared with WT controls (Fig. 4). When subjected to the
IA induction protocol, these lymphocyte-deficient ani-
mals displayed significantly reduced susceptibility to the
disease. Rag1 animals formed fewer IAs than controls,
suffered fewer ruptures, and demonstrated a lower rup-
ture rate (Fig. 1). Histologically, the trend toward in-
creased aneurysm size and wall thickness in the Rag1
group suggests that lymphocytes may be more involved
in aneurysm rupture over formation. This will be ex-
plored in subsequent studies. It is likely that the signifi-
cant differences in IA formation and rupture seen
between the two groups may be the result of an altered
inflammatory cell response in the Rag1 animals. The ab-
sence of lymphocytes did not completely halt the inflam-
matory process, but it may be possible that the lack of
lymphocytic signaling molecules altered IA pathogenesis
in this model. This process was investigated by gene ex-
pression analysis, which showed several key differences
between the WT and Rag1 groups.
RT-PCR was performed on cerebral artery tissue col-
lected from the groups at 2 weeks for VSMC marker,
matrix remodeling, and inflammation genes. A histological
study of saccular IAs in 66 patients found that increased
VSMC proliferation and migration, decellularization, de-
generation of ECM, and inflammatory cell infiltration were
the distinctive factors between ruptured and unruptured
tissue samples [21]. Animals that succumbed to SAH be-
fore the end of study were not included for histology and
gene expression, in order to ensure a uniform endpoint of
2 weeks and because the possible delay between death and
tissue collection would have resulted in degradation of the
tissue. Separate analysis of ruptured and unruptured IA
was not performed. Gene expression analysis of IA tissue at
2 weeks showed some key differences which may indicate
the factors contributing to increased IA formation and rup-
ture in the WT experimental group. IL-6 expression was
found to be markedly increased in the Rag1 group com-
pared to controls. IL-6 can act as a pro-inflammatory or
anti-inflammatory cytokine depending on the identity of
the bound receptor. Signaling via the IL-6 receptor (IL6R)
has been shown to have anti-inflammatory effects, although
only certain cell types, including macrophages, express this
receptor. IL-6 binding to a soluble IL6R (sIL6R) complex
with ubiquitously expressed membrane-bound signaling
protein gp130 can initiate pro-inflammatory signaling in
cells that do not express IL6R [30]. Increased systemic and
local tissue expression of IL-6 has been well-characterized
in clinical studies of IA, and although some suggest that
lower IL-6 levels are synonymous with lower rates of IA
rupture [31, 32], other studies have shown that certain
polymorphisms in the IL-6 gene can be protective against
IA [33]. A meta-analysis of IA in a Southern Indian popula-
tion showed that genetic variants in TNF and IFNγ but not
IL-6 were associated with IA [34]. In this study, a signifi-
cantly lower rate of IA rupture was seen with markedly
higher IL-6 tissue expression at 2 weeks. This could poten-
tially implicate the anti-inflammatory role of IL-6 in a sys-
tem lacking B and T lymphocytes, but more work is
needed to confirm or refute this possibility. Future experi-
ments involving Rag1 knockouts treated with or without
IL-6 inhibitors could be useful in further elucidating the
role of this signaling in IA. Expression of MMPs 2 and 9,
gelatinases critical for ECM remodeling, was significantly
lower in the Rag1 knockout tissue compared to the WT ex-
perimental group. These results are consistent with studies
showing that decreased MMP9 expression correlates with
lower IA rupture rates in a mouse elastase model. The role
of MMP2 is less well-characterized as it is constitutively
expressed [35, 36], and a mouse study of MMP2 knockouts
showed no difference in IA incidence compared to WT
controls [25]. Elevated expression of MMPs 2 and 9 have
also been confirmed in patient IA tissue [37, 38], and Jin et
al. found higher MMPs 2 and 9 expression in ruptured ver-
sus unruptured IA [39].
VSMC phenotypic modulation, proliferation, and mi-
gration from the tunica media are features of IA path-
ology. The VSMC dedifferentiate to a pro-inflammatory,
pro-matrix remodeling phenotype, which is character-
ized by reduced expression of contractile proteins such
as SMA and MHC and actin-binding proteins such as
SM22 [15]. In this study, the reduction in expression of
MHC was attenuated in Rag1 mice, although SMA and
SM22 expression was similar between Rag1 and WT
mice. It has been noted that SMA and SM22 may be
expressed in other cell types following vascular injury
[40, 41] while MHC is exclusively expressed in cells of
myogenic lineage and is considered a more specific
marker of VSMC phenotype [42]. Sibon et al. showed a
time-dependent decrease in MHC but not SMA gene
expression over 6 months in a rat carotid ligation model
of IA [43]. The absence of lymphocytes in the Rag1 tis-
sue may have impeded the phenotypic modulation in the
VSMC resulting in lower expression of MMPs 2 and 9
and higher expression of MHC.
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The present study is characterized by a number of lim-
itations that should be addressed in future work. Gene
expression data for MMPs were not followed by mea-
surements of MMP activity due to tissue quantity limita-
tions. The choice to use Rag1 knockout mice was
effective in allowing the study of aneurysm formation in
the complete absence of lymphocytes, but it is possible
that these knockout animals could display developmen-
tal abnormalities or compensatory mechanisms that
could influence IA pathogenesis in unpredictable ways.
Additionally, there is some evidence to suggest that
Rag1 knockouts display a moderated increase in blood
pressure with DOCA administration [44]. Blood pressure
measurements were not obtained in the current study
due to institutional quarantine procedures for these
immune-deficient animals undergoing multiple surger-
ies. Future studies examining the temporal course and
magnitude and blood pressure changes are underway
using implanted telemetry devices. However, hyperten-
sion is induced in this model via a multi-pronged ap-
proach, and the present data suggest that lymphocytes
may contribute to IA pathogenesis through mechanisms
unrelated to hypertension.
Following this novel identification of lymphocytes as a
contributing factor to IA rupture, it will be important to
further elucidate the specific mechanisms by which these
cells exert their effects. At this point, it is unknown
which subpopulations of lymphocytes are responsible—it
would be appropriate for further experiments to test the
contributions of T cells versus B cells, helper T cells, and
regulatory T cells. These subpopulations have varying
and contradictory effects on the inflammatory cascade
[14], and it is likely that the study of lymphocytes as a
general category in this experiment simplifies the contri-
butions of these cells to the disease process. In addition,
the relevant signaling pathways need to be further char-
acterized. Identification of these mechanistic underpin-
nings could provide the basis for the development of
therapeutics useful in the prevention of IA progression
to rupture.
Conclusions
These data suggest that lymphocytes play an important
role in IA pathogenesis in a well-characterized mouse
model. The lack of these cells led to altered VSMC acti-
vation following IA induction. More specifically, vessel
wall changes contributing to the pathogenesis of IA, in-
cluding increased expression of pro-matrix remodeling
genes and a reduction in expression of MHC, were
attenuated in Rag1 animals lacking lymphocytes com-
pared to wild-type controls. Consequently, lymphocyte-
deficient Rag1 animals demonstrated a significantly
lower rate of aneurysm formation and rupture. Future
studies to delineate mechanisms by which lymphocytes
contribute to IA pathogenesis may uncover novel
putative therapeutic targets.
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